
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Mucuna pruriens extract contains 3.5-7% L-DOPA, a direct precursor to dopamine that crosses the blood-brain barrier to increase brain dopamine levels. This dopaminergic activity supports mood regulation, cognitive function, and neuroprotection against oxidative stress.

Reported Benefits (Provisional)
Origin & History

Mucuna Pruriens Extract is derived from the seeds of the Mucuna pruriens plant, a tropical legume native to Africa and Asia. The extract is rich in L-DOPA, a precursor to the neurotransmitter dopamine.
Research Narrative (Provisional)
Mucuna Pruriens has been studied in RCTs and observational studies, showing benefits in mood enhancement and Parkinson's disease symptom management.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Rich in L-DOPA, a direct precursor to dopamine. - Contains minor amounts of protein and other plant nutrients. - Provides antioxidants that support overall health.
Reported Mechanism (Provisional)
L-DOPA from mucuna pruriens crosses the blood-brain barrier and converts to dopamine via aromatic L-amino acid decarboxylase in dopaminergic neurons. This increases dopamine concentrations in the substantia nigra and striatum, enhancing dopaminergic neurotransmission. The extract also contains antioxidant compounds that protect dopaminergic neurons from oxidative damage and mitochondrial dysfunction.
Clinical Narrative (Provisional)
Randomized controlled trials with 60-120 participants show mucuna pruriens extract (15-30g daily) improved Parkinson's symptoms comparably to synthetic L-DOPA with fewer side effects. Studies demonstrate 23-30% improvements in mood scores and cognitive performance in healthy adults taking 500mg standardized extract daily. Limited long-term safety data exists, with most trials lasting 12-16 weeks. Evidence is moderate quality but promising for dopamine-related conditions.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







